Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Minke He"'
Autor:
Guanwen Yang, Jiangting Cheng, Jiayi Xu, Chenyang Shen, Xuwei Lu, Chang He, Jiaqi Huang, Minke He, Jie Cheng, Hang Wang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract Background Clear cell renal cell carcinoma is a prototypical tumor characterized by metabolic reprogramming, which extends beyond tumor cells to encompass diverse cell types within the tumor microenvironment. Nonetheless, current research on
Externí odkaz:
https://doaj.org/article/24e871aee29b40a4ab8a67fb4f73d179
Autor:
YeXing Huang, ZeFeng Du, Anna Kan, MinKe He, HuiFang Li, ZhiCheng Lai, DongSheng Wen, LiChang Huang, QiJiong Li, Li Xu, Ming Shi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundIntrahepatic cholangiocarcinoma (iCCA) is a highly aggressive cancer with a dismal prognosis and few effective therapeutic approaches. This study aimed to investigate the efficacy, safety, and predictive biomarkers of hepatic arterial infus
Externí odkaz:
https://doaj.org/article/5224fab5b8674f63864231f4306cafb6
Autor:
Anna Kan, Shuang Liu, Minke He, Dongsheng Wen, Haijing Deng, Lichang Huang, Zhicheng Lai, Yexing Huang, Ming Shi
Publikováno v:
JHEP Reports, Vol 6, Iss 1, Pp 100939- (2024)
Background & Aims: The mechanism underlying resistance to immunotherapy involves engagement of immune checkpoint pathways. The transcriptional and epigenetic processes of checkpoint molecules, however, have not been well investigated. We thus studied
Externí odkaz:
https://doaj.org/article/cda62f388495470fb94d6ce8c3575d80
Autor:
Zhicheng Lai, Yexing Huang, Dongsheng Wen, Xuanjia Lin, Anna Kan, Qijiong Li, Wei Wei, Minshan Chen, Li Xu, Minke He, Ming Shi
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin and 5-fluorouracil was effective in unresectable hepatocellular carcinoma (HCC). The program of FOLFOX-HAIC in HCC was performed for 1 day (HAIC 1d) or 2 days (HAIC 2d
Externí odkaz:
https://doaj.org/article/6c6f5b7452a94a5a866f167f52c6a8f9
Autor:
Xuwei Lu, Chang He, Sihong Zhang, Fan Yang, Zhuifeng Guo, Jiaqi Huang, Minke He, Jiawen Wu, Xia Sheng, Wenyao Lin, Jie Cheng, Jianming Guo, Hang Wang
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Radical prostatectomy (RP) is the primary treatment of localized prostate cancer. Immediate urinary incontinence post-RP was still common and depressing without specific reason. Methods A multicenter cohort of 154 consecutive pati
Externí odkaz:
https://doaj.org/article/f831d2bca2e94833b1d44bd9b6421a92
Autor:
YeXing Huang MD, LiHong Zhang MD, MinKe He MD, ZhiCheng Lai MD, XiaoYun Bu MD, DongSheng Wen MD, QiJiong Li MD, Li Xu MD, Wei Wei MD, YaoJun Zhang MD, ZhongGuo Zhou MD, MinShan Chen MD, RongPing Guo MD, Ming Shi MD, Anna Kan MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Purpose: Sorafenib is recommended for patients with hepatocellular carcinoma refractory to transarterial chemoembolization but with unsatisfactory overall survival and tumor response rate. Previously published studies showed hepatic arterial infusion
Externí odkaz:
https://doaj.org/article/2c4d346d31d64fcaa1e66600e00e7d9f
Autor:
MinKe He, Qing Li, JingXian Shen, GuoSheng Tan, QiJiong Li, JiaYing Lai, Wei Wei, YaoJun Zhang, RuHai Zou, MinShan Chen, RongPing Guo, Ming Shi
Publikováno v:
Cancer Medicine, Vol 8, Iss 9, Pp 4200-4213 (2019)
Abstract Background Compared with single‐drug TACE, our previous phase III study demonstrated that triple‐drug transarterial chemoembolization (TACE) prolonged overall survival (OS) in patients with unresectable hepatocellular carcinoma (HCC). Th
Externí odkaz:
https://doaj.org/article/db14e88e194642568096b880da4e291f
Publikováno v:
Journal of Interventional Medicine, Vol 2, Iss 2, Pp 78-83 (2019)
Objective: To compare the efficacy of sorafenib plus hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin to that of sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). Methods: This was a retrospective, single-center
Externí odkaz:
https://doaj.org/article/c127065db8e64f66a58ac63dad2ec98b
Autor:
Xuwei Lu, Chang He, Sihong Zhang, Fan Yang, Zhuifeng Guo, Jiaqi Huang, Minke He, Jiawen Wu, Xia Sheng, Wenyao Lin, Jie Cheng, Jianming Guo, Hang Wang
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/91b0870a44bf488b8d52e8e8b7a29230
Autor:
ZhiCheng Lai, MinKe He, XiaoYun Bu, YuJie Xu, YeXing Huang, DongSheng Wen, QiJiong Li, Li Xu, YaoJun Zhang, Wei Wei, MinShan Chen, Anna Kan, Ming Shi
Publikováno v:
European Journal of Cancer. 174:68-77
The combination of lenvatinib, toripalimab and hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) suggested encouraging antitumour activity in our retrospective study. We hereby prospectively estab